Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Fuji
Merck
Cerilliant
Deloitte
Covington
Accenture
Baxter

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 083004

« Back to Dashboard

NDA 083004 describes STILBESTROL, which is a drug marketed by Bristol Myers Squibb and Tablicaps and is included in seven NDAs. Additional details are available on the STILBESTROL profile page.

The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
Summary for 083004
Tradename:STILBESTROL
Applicant:Tablicaps
Ingredient:diethylstilbestrol
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 083004

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Army
Cipla
Mallinckrodt
Deloitte
Citi
Harvard Business School
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.